Inventory / revenue moved 262 bp lower
Inventory / revenue changed -262 basis points from the comparable as-filed period.
21.96%→19.34%3 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory / revenue changed -262 basis points from the comparable as-filed period.
SBC / revenue changed -604 basis points from the comparable as-filed period.
Research & development changed +15.1% from the comparable as-filed period.
Stock-based compensation changed -13.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.